Edwards Lifesciences logo

Edwards Lifesciences Business Segments

Business, geographic, and product segment breakdowns

Edwards Lifesciences generates $6.3B in annual revenue across 4 key segments: Europe ($1.6B), Japan ($363.5M), Rest of World ($679.9M), and United States ($3.6B). The company-wide operating margin is 21.37%. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-05-06
Market Cap$46.9B
P/E Ratio42.75
ROE10.72%

Products & Services

Geographic

Carryforward amount

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
International$6.0M$0.0

Carryforward Amount

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other countries$517.8M$575.4M

Tax Benefit Amount

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other countries$89.3M$104.5M

Business Segments